Andrew Huberman· PhD
So by that principle, I'm interested in that combination and whether it does offer some advantages, maybe, in certain patients.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So by that principle, I'm interested in that combination and whether it does offer some advantages, maybe, in certain patients.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Whereas what MDMA offers is something arguably more directionally reliable in terms of the valence. It's more directionally positive generally, an MDMA experience.